Objective of the review:

to determine if the information and communications technology-based care alternatives support treatment adherence in adult patients with type 2 diabetes mellitus.

Source of the data:

Medline, Embase, Scopus and Lilacs.

Study selection:

a rapid review of the literature was performed using the terms telemedicina, telemonitoreo, adherencia terapéutica and diabetes mellitus tipo 2. Controlled clinical trials, and pre-post or observational cohort studies from January 2008 to December 2018 in English and Spanish were included. Data analysis and extraction were conducted independently by two authors. The measured outcome was adherence in its various dimensions. The results are presented descriptively. Neither a meta-analysis nor subgroup analyses were considered.

Data extraction and synthesis:

The search yielded a total of 466 studies, 29 articles of which were included (clinical trials n=17, pre-post n=7 and cohort n=3). The most commonly used technology was smartphones (n=8; 27.5%), followed by traditional telephones (n=7; 24.1%). In 22 studies, HbA1c was measured to evaluate adherence, with positive results in 15 (68%). Non-pharmacological adherence was measured in 16 studies, with positive results in 13 (81.25%).

Conclusions:

different technologies have a positive impact on adherence measured through HbA1c, with smartphones and conventional telephones being the most used. The evidence is low-quality and therefore more studies of this problem are needed. (Acta Med Colomb 2022; 48. DOI:https://doi.org/10.36104/amc.2023.2826).

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )